Evidence map›Paper›PMID 26292219›Full record

ArticleThe Journal of biological chemistry2015

Transcription Factor Hepatocyte Nuclear Factor-1β (HNF-1β) Regulates MicroRNA-200 Expression through a Long Noncoding RNA.

Sachin S Hajarnis, Vishal Patel, Karam Aboudehen, Massimo Attanasio, Patricia Cobo-Stark, Marco Pontoglio, Peter Igarashi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Loss ofbioRxiv : the preprint server for biology · 2026
    Article
  3. Clinical kidney journal · 2026
    Review
  4. Gene therapy in polycystic kidney disease: A promising future.Journal of translational internal medicine · 2024
    Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Non-Coding RNAs in Hereditary Kidney Disorders.International journal of molecular sciences · 2021
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. New insights into the role of HNF-1β in kidney (patho)physiology.Pediatric nephrology (Berlin, Germany) · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Sachin S HajarnisFrom the Departments of Internal Medicine and.
Vishal PatelFrom the Departments of Internal Medicine and.
Karam AboudehenFrom the Departments of Internal Medicine and.
Massimo AttanasioFrom the Departments of Internal Medicine and.
Patricia Cobo-StarkFrom the Departments of Internal Medicine and.
Marco PontoglioDépartment de Génétique et Développement, INSERM U1016, CNRS UMR 8104, Université Paris-Descartes. Institut Cochin, 75014 Paris, France.
Peter IgarashiFrom the Departments of Internal Medicine and Pediatrics, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 and igarashi@umn.edu.
The University of Texas Southwestern Medical Center · USInstitut Cochin · FR

Funding

UT Southwestern Center for Translational Medicine (UL1/KL2/TL1)UL1TR001105 · NCATS · UT SOUTHWESTERN MEDICAL CENTER · PI TOTO, ROBERT DANIEL · 2013 to 2017
$24.5M
UT Southwestern O'Brien Kidney Research Core CenterP30DK079328 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI MOE, ORSON W · 2007 to 2021
$16.9M
RENAL CONTROL OF BODY COMPOSITION AND BLOOD PRESSURET32DK007257 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI BAUM, MICHEL GERARD, MOE, ORSON W · 1986 to 2021
$5.0M
Regulation of Kidney-Specific Gene ExpressionR37DK042921 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI IGARASHI, PETER · 2011 to 2020
$3.6M
The impact of RNA chemical modifications on polycystic kidney disease progressionR01DK102572 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI PATEL, VISHAL · 2015 to 2024
$3.5M
Role of GLIS2 in the Development of Cystic Kidney DiseaseR01DK090326 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI ATTANASIO, MASSIMO · 2012 to 2016
$1.7M
Role of microRNA in kidney development and pathogenesis of PKDK08DK084311 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI PATEL, VISHAL · 2009 to 2013
$728k
NCATS NIH HHS UL1 TR001105NIDDK NIH HHS K08 DK084311NIDDK NIH HHS K08DK084311NIDDK NIH HHS P30 DK079328NIDDK NIH HHS P30DK079328NIDDK NIH HHS R01 DK090326NIDDK NIH HHS R01 DK102572NIDDK NIH HHS R37 DK042921NIDDK NIH HHS R37DK042921NIDDK NIH HHS T32 DK007257NIDDK NIH HHS T32DK007257
6 · The paper itself

Abstract

The transcription factor hepatocyte nuclear factor-1β (HNF-1β) regulates tissue-specific gene expression in the kidney and other epithelial organs. Mutations of HNF-1β produce kidney cysts, and previous studies have shown that HNF-1β regulates the transcription of cystic disease genes, including Pkd2 and Pkhd1. Here, we combined chromatin immunoprecipitation and next-generation sequencing (ChIP-Seq) with microarray analysis to identify microRNAs (miRNAs) that are directly regulated by HNF-1β in renal epithelial cells. These studies identified members of the epithelial-specific miR-200 family (miR-200b/200a/429) as novel transcriptional targets of HNF-1β. HNF-1β binds to two evolutionarily conserved sites located 28 kb upstream to miR-200b. Luciferase reporter assays showed that the HNF-1β binding sites were located within a promoter that was active in renal epithelial cells. Mutations of the HNF-1β binding sites abolished promoter activity. RT-PCR analysis revealed that a long noncoding RNA (lncRNA) is transcribed from the promoter and encodes the miR-200 cluster. Inhibition of the lncRNA with siRNAs decreased the levels of miR-200 but did not affect expression of the Ttll10 host gene. The expression of the lncRNA and miR-200 was decreased in kidneys from HNF-1β knock-out mice and renal epithelial cells expressing dominant-negative mutant HNF-1β. The expression of miR-200 targets, Zeb2 and Pkd1, was increased in HNF-1β knock-out kidneys and in cells expressing mutant HNF-1β. Overexpression of miR-200 decreased the expression of Zeb2 and Pkd1 in HNF-1β mutant cells. These studies reveal a novel pathway whereby HNF-1β directly contributes to the control of miRNAs that are involved in epithelial-mesenchymal transition and cystic kidney disease.

Indexed as

Gene Expression RegulationAnimalsBase SequenceEpithelial CellsGene Knockout TechniquesGenomicsHeLa CellsHepatocyte Nuclear Factor 1-betaHomeodomain ProteinsHumansKidneyMiceMicroRNAsMutationRepressor ProteinsRNA, Long NoncodingHepatocyte Nuclear Factor 1-betaHnf1b protein, mouseHomeodomain ProteinsMicroRNAsMirn200 microRNA, mouseRepressor ProteinsRNA, Long NoncodingTRPP Cation ChannelsZEB2 protein, humanZinc Finger E-box Binding Homeobox 2ChIP-sequencing (ChIP-seq)epithelial-mesenchymal transition (EMT)hepatocyte nuclear factor 1 (HNF-1)kidneylong noncoding RNA (long ncRNA, lncRNA)microRNA (miRNA)transcription regulation

Identifiers

PMID26292219
PMCPMC4598991
OpenAlexW2211441368

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.